Back to results
US 2019/0071405 A1Published application
Triazoles as kv3 inhibitors
AssigneeAutifony Therapeutics Limited
InventorsAgostino Marasco, Giuseppe Alvaro, Anne Dècor, Dieter Hamprecht, Paolo Dambruoso, Simona Tommasi
Life of this patent
Estimating the term…
Abstract
Compounds of formula (I) are of use in the modulation of Kv3.1, Kv.3.2 and Kv3.3 channels and have utility in the treatment or prevention of related disorders.
Claims11
A compound of formula (VII):
- wherein:
- Z is F, Cl, Br, or I;
- X is CH or N;
- Y is N;
- and
- R4 is H or C1-4 alkyl;
- with the proviso that when R4 is H, X is CH then Z is not Cl.
4 more elements
Dependencies are inferred from the claim text.